Skip to main navigation Skip to search Skip to main content

3-(p-Nitrobenzyl)-1,3-thiazolidine-2,4-dione

  • Hemmige S. Yathirajan
  • , Kuriya M. Lokanatha Rai
  • , Santhosh L. Gaonkar
  • , Rajenahally S. Narasegowda
  • , Basappa Prabhuswamy
  • , Michael Bolte*
  • *Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    Abstract

    The structural properties of C10H8N2O 4S compound were studied. The compound was investigated as a PPAR-γ-agonist that leads to the development of several insulin-sensitizing drugs for the treatment of diabetes. The compound serves as a starting material for the synthesis of antihyperglycemic pharmaceuticals. It was observed that the planar thiazolidine-2,4-dione ring is almost perpendicular to the nitrophenyl ring in the compound, which describes its crystal structure.

    Original languageEnglish
    Pages (from-to)o245-o246
    JournalActa Crystallographica Section E: Structure Reports Online
    Volume61
    Issue number2
    DOIs
    Publication statusPublished - 02-2005

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    All Science Journal Classification (ASJC) codes

    • General Chemistry
    • General Materials Science
    • Condensed Matter Physics

    Fingerprint

    Dive into the research topics of '3-(p-Nitrobenzyl)-1,3-thiazolidine-2,4-dione'. Together they form a unique fingerprint.

    Cite this